首页> 外文期刊>Molecular biology of the cell >ADP Ribosylation Factors 1 and 4 and Group VIA Phospholipase A2 Regulate Morphology and Intraorganellar Traffic in the Endoplasmic Reticulum–Golgi Intermediate Compartment
【24h】

ADP Ribosylation Factors 1 and 4 and Group VIA Phospholipase A2 Regulate Morphology and Intraorganellar Traffic in the Endoplasmic Reticulum–Golgi Intermediate Compartment

机译:ADP核糖基化因子1和4以及VIA组磷脂酶A2调节内质网-高尔基体中隔室的形态和细胞内运输

获取原文
           

摘要

Organelle morphology of the endomembrane system is critical for optimal organelle function. ADP ribosylation factors (Arfs), a family of small GTPases, are required for maintaining the structure of the Golgi and endosomes. What determines the discontinuous nature of the endoplasmic reticulum (ER)–Golgi intermediate compartment (ERGIC) as tubulovesicular clusters is unknown. In search of morphological determinants for the ERGIC, we found that a double knockdown of Arf1+Arf4 induced dynamic ERGIC tubules that connect ERGIC clusters, indicating that the tubules mediated lateral intraERGIC traffic. Tubule formation was inhibited by an antagonist of group VI calcium-independent phospholipase A2 (PLA2G6) and by silencing the A isoform of PLA2G6 (PLA2G6-A). Arf1+Arf4 depletion altered the expression of PLA2G6-A splice variants and relocalized PLA2G6-A from the cytosol to ERGIC clusters and tubules, suggesting that the enzyme became locally active. We show that changes in Arf1 can modulate the activity of PLA2G6-A. We propose that a concerted action of Arf1, Arf4, and PLA2G6-A controls the architecture of the ERGIC in a way that is predicted to impact the rate and possibly the destination of cargos. Our findings have identified key components in the molecular mechanism underlying the regulation of tubules in the ERGIC and uncover tubular carriers as tightly controlled machinery.
机译:内膜系统的细胞器形态对于最佳细胞器功能至关重要。 ADP核糖基化因子(Arfs)是一个小的GTPases家族,是维持高尔基体和内体的结构所必需的。决定内质网(ER)–高尔基体中间隔室(ERGIC)作为微管网状簇的不连续性的原因尚不清楚。在寻找ERGIC的形态学决定因素时,我们发现Arf1 + Arf4的双重敲低诱导了连接ERGIC簇的动态ERGIC小管,表明这些小管介导了侧向ERGIC内交通。 VI组钙独立的磷脂酶A 2 (PLA2G6)的拮抗剂和PLA2G6的A亚型(PLA2G6-A)沉默可抑制肾小管的形成。 Arf1 + Arf4耗竭改变了PLA2G6-A剪接变体的表达,并将PLA2G6-A从胞质溶胶重新定位到ERGIC簇和小管,表明该酶具有局部活性。我们表明Arf1的变化可以调节PLA2G6-A的活性。我们建议Arf1,Arf4和PLA2G6-A的协调行动以预计会影响运价和可能到达目的地的方式来控制ERGIC的体系结构。我们的发现确定了ERGIC中小管调节的分子机制中的关键成分,并发现了作为严格控制机制的管状载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号